Skip NavigationSkip to Content

Harnessing Ionic Selectivity in Acetyltransferase Chemoproteomic Probes

  1. Author:
    Jing, Yihang
    Montano, Jose L.
    Levy, Michaella
    Lopez, Jeffrey E.
    Kung, Pei-Pei
    Richardson, Paul
    Krajewski, Krzysztof
    Florens, Laurence
    Washburn, Michael P.
    Meier, Jordan L.
  2. Author Address

    NCI, Chem Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA.Stowers Inst Med Res, Kansas City, MO 64110 USA.Pfizer Inc, Worldwide Res & Dev, San Diego, CA 92121 USA.Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA.
    1. Year: 2021
    2. Date: Jan 15
  1. Journal: ACS Chemical Biology
  2. Amer Chemical Soc
    1. 16
    2. 1
    3. Pages: 27-34
  3. Type of Article: Article
  4. ISSN: 1554-8929
  1. Abstract:

    Chemical proteomics provides a powerful strategy for the high-throughput assignment of enzyme function or inhibitor selectivity. However, identifying optimized probes for an enzyme family member of interest and differentiating signal from the background remain persistent challenges in the field. To address this obstacle, here we report a physiochemical discernment strategy for optimizing chemical proteomics based on the coenzyme A (CoA) cofactor. First, we synthesize a pair of CoA-based sepharose pulldown resins differentiated by a single negatively charged residue and find this change alters their capture properties in gel-based profiling experiments. Next, we integrate these probes with quantitative proteomics and benchmark analysis of "probe selectivity" versus traditional "competitive chemical proteomics." This reveals that the former is well-suited for the identification of optimized pulldown probes for specific enzyme family members, while the latter may have advantages in discovery applications. Finally, we apply our anionic CoA pulldown probe to evaluate the selectivity of a recently reported small molecule N-terminal acetyltransferase inhibitor. These studies further validate the use of physical discriminant strategies in chemoproteomic hit identification and demonstrate how CoA-based chemoproteomic probes can be used to evaluate the selectivity of small molecule protein acetyltransferase inhibitors, an emerging class of predinical therapeutic agents.

    See More

External Sources

  1. DOI: 10.1021/acschembio.0c00766
  2. PMID: 33373188
  3. WOS: 000611444900005

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel